Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Specialists held on Monday, June 27, 2022. The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This webinar is targeted towards medical oncologists, urologists and radiation oncologists. Hear from experts: Ali Khakhi, MD, Andrei Iagaru, MD, Sumit Shah, MD and Sandy Srinivas, MD. Topics will include: germline and somatic testing, risk stratification for localized prostate cancer and answer questions on when to do prostatectomy vs radiation.
Sign in to take quiz and track your certificates
To help improve the quality of its educational content and meet applicable education accreditation requirements, the content provider will receive record of your participation and responses to this activity.
Stanford Medicine offers CME on a variety of topics that is evidence-based, references best practices supported by scientific literature and guidelines and is free of commercial bias. Learn more
All Rights Reserved. The content of this activity is protected by U.S. and International copyright laws. Reproduction and distribution of its content without written permission of its creator(s) is prohibited.
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement: Stanford Medicine designates this live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Financial Support Disclosure Statement: Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.
There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.
Sumit Anil Shah, MD
Advisor-Natera|Grant or research support-Genentech, Inc.
Ali R Khaki, MD
Clinical Assistant Professor
Stanford Health Care (SHC)
Co-Course Director, Faculty
Stocks or stock options, excluding diversified mutual funds-Merck and Company, Inc. (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Sanofi-Aventis (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Doximity (Relationship has ended)
Hilary Petersmeyer Bagshaw, MD
Nothing to disclose
Benjamin Inbeh Chung, MD
Consulting Fee-Johnson and Johnson|Honoraria-Intuitive Surgical
Andrei Horia Iagaru, MD
Advisor-GE Healthcare Bio-Sciences|Advisor-Novartis AG|Advisor-Lantheus|Advisor-Clarity Pharmaceuticals|Advisor-ITM
Sandhya Srinivas, MD
Advisor-Bayer Corporation|Advisor-Johnson and Johnson|Advisor-Merck and Company, Inc.|Advisor-Novartis AG
Laura Ruffo, NP
Ruth Adewuya, MD, CHCP
Managing Director, CME
Stanford University School of Medicine
You currently have no searches saved.
You currently have no courses saved.